Cleared Traditional

visor2 system (K210109) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K210109 · Eemagine Medical Imaging Solutions GmbH · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
444d
Days
Class 2
Risk

K210109 is an FDA 510(k) clearance for the visor2 system. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Eemagine Medical Imaging Solutions GmbH (Berlin, DE). The FDA issued a Cleared decision on April 8, 2022 after a review of 444 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Eemagine Medical Imaging Solutions GmbH devices

Submission Details

510(k) Number K210109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 2021
Decision Date April 08, 2022
Days to Decision 444 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
296d slower than avg
Panel avg: 148d · This submission: 444d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Quality & Regulatory Associates, LLC
Gary J Syring

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 159
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K210109.
Synergy Cranial v2.2.9, StealthStation Cranial v3.1.4
K221087 · Medtronic Navigation, Inc. · Jun 2022
ROSA ONE Brain application
K214065 · Medtech S.A.S · May 2022
ClearPoint Array System (version 1.1)
K214040 · ClearPoint Neuro, Inc. · Apr 2022
StealthStation S8 Cranial v2.0
K212397 · Medtronic Navigation · Dec 2021
Molecular Flow Simulations
K201435 · Therataxis, LLC · Dec 2021
Cirq, Cirq Robotic Alignment System, Cirq Robotic Alignment Module Cranial, Cirq Robotic Alignment Module, Cirq Robotic Alignment Cranial And Spine, CIRQ Robotic Alignment Cranial and Spine System
K210989 · Brainlab AG · Nov 2021